Doxazosin
NDC 59651-893, doxazosin mesylate, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 59651-893
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075509
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-893 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXAZOSIN MESYLATE2 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-893-01 | 59651089301 | 100 TABLET in 1 BOTTLE (59651-893-01) |
| 59651-893-99 | 59651089399 | 1000 TABLET in 1 BOTTLE (59651-893-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/93f2d724-5a54-4721-b04a-e46bc764607bNADAC price for package 59651089301
GET /v1/drugs/nadac/59651089301NADAC price for package 59651089399
GET /v1/drugs/nadac/59651089399
Use it
Look up 59651-893 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-893 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-893. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.